berberine has been researched along with Arterial Occlusive Diseases in 1 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine was found to inhibit platelet aggregation, superoxide production via modulating AR, NOX, and glutathione reductase activities in high glucose (HG) treated platelets." | 1.51 | Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. ( Girish, KS; Hemshekhar, M; Kemparaju, K; Paul, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, M | 1 |
| Hemshekhar, M | 1 |
| Kemparaju, K | 1 |
| Girish, KS | 1 |
1 other study available for berberine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity.
Topics: Aldehyde Reductase; Antioxidants; Apoptosis; Arterial Occlusive Diseases; Berberine; Blood Platelets | 2019 |